Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.64 is 82% above its 5-year average of 0.90, near the high end of its 5-year range (0.40–2.12).
As of the fiscal period ended Tuesday, June 30, 2026. 25.58% above its 12-month average of 1.31.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.64.
QUICK RATIO (ACID-TEST)
1.64
QUICK RATIO (ACID-TEST) AVG TTM
1.31
QUICK RATIO (ACID-TEST) AVG 3Y
0.62
QUICK RATIO (ACID-TEST) AVG 5Y
0.90
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+25.58%
CURRENT VS 3Y AVG
+164.59%
CURRENT VS 5Y AVG
+82.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.99
median of 565 covered companies
CURRENT VS SECTOR MEDIAN
-45.07%
vs the sector median at left
Market Cap
$36.32M
Quick Ratio (Acid-Test)
2.77
TTM Avg
2.09
3Y Avg
1.85
5Y Avg
2.65
Market Cap
$36.45M
Quick Ratio (Acid-Test)
7.07
TTM Avg
2.75
3Y Avg
16.37
5Y Avg
28.22
Market Cap
$36.64M
Quick Ratio (Acid-Test)
0.74
TTM Avg
0.82
3Y Avg
0.89
5Y Avg
0.96
Market Cap
$34.44M
Quick Ratio (Acid-Test)
11.47
TTM Avg
9.93
3Y Avg
10.68
5Y Avg
16.03
Market Cap
$37.81M
Quick Ratio (Acid-Test)
2.76
TTM Avg
5.79
3Y Avg
4.84
5Y Avg
5.49
Market Cap
$33.32M
Quick Ratio (Acid-Test)
3.61
TTM Avg
1.56
3Y Avg
4.91
5Y Avg
7.24
Market Cap
$38.60M
Quick Ratio (Acid-Test)
0.98
TTM Avg
0.82
3Y Avg
0.91
5Y Avg
1.06
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elutia Inc (ELUT) | $35.82M | 1.64 | 1.31 | 0.62 | 0.90 |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.32M | 2.77 | 2.09 | 1.85 | 2.65 |
| BriaCell Therapeutics Corp. (BCTX)vs › | $36.45M | 7.07 | 2.75 | 16.37 | 28.22 |
| Accuray Incorporated (ARAY)vs › | $36.64M | 0.74 | 0.82 | 0.89 | 0.96 |
| DocGo Inc. (DCGO)vs › | $36.70M | 1.66 | 2.38 | 2.35 | 2.72 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.44M | 11.47 | 9.93 | 10.68 | 16.03 |
| Edesa Biotech, Inc. (EDSA)vs › | $37.81M | 2.76 | 5.79 | 4.84 | 5.49 |
| HeartBeam, Inc. (BEAT)vs › | $33.32M | 3.61 | 1.56 | 4.91 | 7.24 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.60M | 0.98 | 0.82 | 0.91 | 1.06 |
| Incannex Healthcare Limited (IXHL)vs › | $38.82M | 48.81 | 25.84 | 15.89 | 15.79 |
Quick Ratio
1.64
Excludes inventory
Current Ratio
1.77
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.64 |
| 2026-03-31 | 1.94 |
| 2025-12-31 | 2.12 |
| 2025-09-30 | 0.40 |
| 2025-06-30 | 0.45 |
| 2025-03-31 | 0.70 |
| 2024-12-31 | 0.59 |
| 2024-09-30 | 0.85 |
| 2024-06-30 | 0.68 |
| 2024-03-31 | 0.55 |
| 2023-12-31 | 0.64 |
| 2023-09-30 | 0.73 |
| 2023-06-30 | 0.63 |
| 2023-03-31 | 0.78 |
| 2022-12-31 | 1.09 |
| 2022-09-30 | 0.83 |
| 2022-06-30 | 0.72 |
| 2022-03-31 | 1.14 |
| 2021-12-31 | 1.46 |
| 2021-09-30 | 1.31 |
